APA (7th ed.) Citation

Oudah, K. H., Najm, M. A. A., Ramsis, T. M., Ebrahim, M. A., Gohar, N. A., Abu-Elfotuh, K., . . . Fayed, E. A. (2025). Unlocking Therapeutic Potential of Novel Thieno-Oxazepine Hybrids as Multi-Target Inhibitors of AChE/BChE and Evaluation Against Alzheimer's Disease: In Vivo, In Vitro, Histopathological, and Docking Studies. Pharmaceuticals (14248247), 18(8), 1214. https://doi.org/10.3390/ph18081214

Chicago Style (17th ed.) Citation

Oudah, Khulood H., et al. "Unlocking Therapeutic Potential of Novel Thieno-Oxazepine Hybrids as Multi-Target Inhibitors of AChE/BChE and Evaluation Against Alzheimer's Disease: In Vivo, In Vitro, Histopathological, and Docking Studies." Pharmaceuticals (14248247) 18, no. 8 (2025): 1214. https://doi.org/10.3390/ph18081214.

MLA (9th ed.) Citation

Oudah, Khulood H., et al. "Unlocking Therapeutic Potential of Novel Thieno-Oxazepine Hybrids as Multi-Target Inhibitors of AChE/BChE and Evaluation Against Alzheimer's Disease: In Vivo, In Vitro, Histopathological, and Docking Studies." Pharmaceuticals (14248247), vol. 18, no. 8, 2025, p. 1214, https://doi.org/10.3390/ph18081214.